Breaking News Instant updates and real-time market news.

EA

Electronic Arts

$102.25

-0.12 (-0.12%)

, AMZN

Amazon.com

$1,639.90

2.045 (0.12%)

18:28
02/13/19
02/13
18:28
02/13/19
18:28

EA's 'Apex Legends' drew 688,000 peak live viewers on Twitch, Reuters says

EA's (EA) latest game "Apex Legends" is posing a real online threat to Epic Games' "Fortnite," particularly on Amazon's (AMZN) Twitch streaming platform, Jane Lanhee Lee of Reuters reports. After impressing investors with its enormous launch, "Apex Legends" fell briefly to the second spot on Twitch before retaking first place, Lee notes. "Apex" has made a strong showing on Twitch, reaching 688,000 peak live viewers, the reporter says. "Apex Legends had a massive first week on Twitch. It generated more hours watched than any other game during its launch week in our history," Michael Aragon, Twitch's senior vice president of content, said in an email. Investors in Epic Games include Tencent (TCEHY), Disney (DIS), and KKR (KKR). Reference Link

EA

Electronic Arts

$102.25

-0.12 (-0.12%)

AMZN

Amazon.com

$1,639.90

2.045 (0.12%)

TCEHY

Tencent

$0.00

(0.00%)

KKR

KKR

$23.50

-0.1 (-0.42%)

DIS

Disney

$110.16

0.97 (0.89%)

  • 14

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

EA Electronic Arts
$102.25

-0.12 (-0.12%)

02/13/19
BMOC
02/13/19
NO CHANGE
Target $116
BMOC
Outperform
Electronic Arts price target raised to $116 from $96 at BMO Capital
BMO Capital analyst Gerrick Johnson raised his price target on Electronic Arts to $116 and kept his Outperform rating after its latest update that Apex Legends player count has reached 25M with "well over" 2M concurrent players at the peak. The analyst believes that the gamer count for the title will continue to expand and for player engagement to remain high, raising his FY19 and FY20 EPS estimates by 6c and 80c respectively to $3.91 and $5.30.
02/13/19
RHCO
02/13/19
NO CHANGE
Target $49
RHCO
Buy
Activision Blizzard price target lowered to $49 from $54 at SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Activision Blizzard (ATVI) to $49, saying the company's reported quarter and guidance were "clearly challenged", with added risk coming from the rising popularity of Electronic Arts' (EA) Apex Legends. The analyst also keeps his Buy rating on the stock, noting that some of its uncertainty has been removed while the management is increasing development investment to accelerate new content. Thornton lowers his FY19 and FY20 EPS by 42c and 43c to $2.25 and $2.50 respectively, adding that his new valuation multiples are in in with historical average and may prove conservative.
02/11/19
BARD
02/11/19
NO CHANGE
Target $106
BARD
Outperform
Electronic Arts price target raised to $106 from $90 at Baird
Baird analyst Colin Sebastian raised his price target on Electronic Arts to $106 and kept his Outperform rating after the company disclosed today that the number of active Apex Legends players has topped 25M since its launch. The analyst states that the launch implies a better start the the "phenom" Fortnite game, which took over 40 days to reach 25M users, adding that while the data on player retention and monetization is limited, an upcoming update from Respawn should give investors more visibility on whether Apex will be a hit.
02/13/19
SPHN
02/13/19
NO CHANGE
Target $57
SPHN
Overweight
Activision Blizzard transition year creates buying opportunity, says Stephens
Stephens analyst Jeff Cohen noted that Activision Blizzard (ATVI), like peers Electronic Arts (EA) and Take-Two (TTWO), gave 2019 guidance that was significantly below consensus and framed it as a transition year. Cohen, who said he feels confident now is the time to be buying as 2019 should represent the trough of earnings power, lowered his price target on the shares to $57 from $65 but keeps an Overweight rating on Activision Blizzard shares.
AMZN Amazon.com
$1,639.90

2.045 (0.12%)

02/12/19
LOOP
02/12/19
NO CHANGE
LOOP
Buy
NEMF liquidation could be boost for LTL companies, says Loop Capital
After New England Motor Freight, or NEMF, announced that it was liquidating, Loop Capital analyst Jeffrey Kauffman noted that the company was the 19th largest LTL carrier by revenues in 2018 and had a reputation as more of a discounter. He believes NEMF's customers, which reportedly includes Amazon (AMZN), will be challenged to find capacity easily with other LTL carriers given the current tightness in the market. The analyst, who said the liquidation should buoy LTL companies, has a Buy rating on YRC Worldwide (YRCW).
02/12/19
DADA
02/12/19
NO CHANGE
Target $60
DADA
Underperform
DA Davidson reiterates $60 target on Wayfair citing Amazon 'encroachment'
In a research earlier today titled "Encroachment Is a 5-Yard Penalty," DA Davidson analyst Tom Forte reiterated an Underperform rating on Wayfair with a $60 12-18 month price target. The stock in morning trading is up 1% to $120.89. Amazon.com (AMZN) announced yesterday that it was launching two private-label furniture brands in the U.K., Forte wrote to investors. The analyst sees the news as "yet another indication" of Amazon's intent to expand its efforts in the home category, including furniture. Yesterday's announcement follows Amazon's decision last December to lower third-party selling fees for the furniture category, the analyst points out. Forte views Amazon's efforts to ramp its sales in the home category as an increasing threat for Wayfair. Further, the analyst is monitoring the potential sale of Overstock's (OSTK) legacy home e-commerce business, as he thinks a sale to a large bricks and mortar retailer could also result in additional competition for Wayfair.
02/08/19
SUSQ
02/08/19
UPGRADE
Target $30
SUSQ
Positive
Air Transport Services upgraded to Positive, target raised to $31 at Susquehanna
As reported previously, Susquehanna analyst Christopher Stathoulopoulos upgraded Air Transport Services (ATSG) to Positive from Neutral. The analyst cited its extended agreement with Amazon (AZMN), which puts its growth still in the early-innings as he sees low double-digit block hour growth in 2019 as achievable. Stathoulopoulos raised his price target to $30 from $21 on Air Transport Services shares.
02/07/19
MSCO
02/07/19
NO CHANGE
Target $99
MSCO
Overweight
PayPal acceptance growth still best of any digital wallet, says Morgan Stanley
Morgan Stanley analyst James Faucette said the most common question he has gotten for the past several weeks on PayPal (PYPL) has been, "Why is the stock underperforming so much since the beginning of 2019?" He believes PayPal's recent plateauing probably has more to do with other stocks than anything stock-specific, stating that Visa (V) and MasterCard (MA) "really have arguably had their best buying opportunities in years" and he would not be surprised to see PayPal "tread water" until those two stocks retake their respective highs. Another common thread in talks has been increasing concern that other digital wallets from Amazon (AMZN), Apple (AAPL) and others may be closing the acceptance gap, though he thinks that "speculation is flatly wrong." Dating back to March 2016, PayPal has had the fastest acceptance growth among all digital wallets, outpacing all the other wallets that he can reliably track, Faucette tells investors. He maintains an Overweight rating and $99 price target on PayPal shares.
TCEHY Tencent
$0.00

(0.00%)

12/12/18
MZHO
12/12/18
DOWNGRADE
MZHO
Neutral
Tencent assumed with a Neutral at Mizuho
Mizuho analyst James Lee assumed coverage on Tencent with a Neutral rating and a price target of HK$345, down from the firm's prior rating of Buy. He sees the company being well positioned in gaming, advertising, payments and commerce, but believes the near-term regulatory and macro environment creates uncertainty for the gaming and ad businesses.
11/08/18
OTRG
11/08/18
DOWNGRADE
OTRG
Mixed
Tencent downgraded to Mixed from Positive at OTR Global
01/14/19
BERN
01/14/19
INITIATION
BERN
Market Perform
Tencent assumed with a Market Perform at Bernstein
Bernstein analyst David Dai assumed coverage on Tencent with a Market Perform.
01/29/19
01/29/19
DOWNGRADE
Target $74

Neutral
YY downgraded to Neutral on slowing Live business at Nomura Instinet
As previously reported, Nomura Instinet analyst Jialong Shi downgraded YY (YY) to Neutral from Buy as the company struggles to find a new driver for its slowing YY Live business, which is facing rising competition from Tencent-backed (TCEHY) Kuaishou and Kugou. Shi cut FY19 revenue and earnings estimates for YY by 3% and 5%, respectively, and lowered the price target on the stock to $74 from $75.
KKR KKR
$23.50

-0.1 (-0.42%)

10/26/18
ARGS
10/26/18
UPGRADE
Target $28
ARGS
Buy
KKR upgraded to Buy at Argus on valuation
As reported earlier, Argus analyst Stephen Biggar upgraded KKR to Buy from Hold with a price target of $28. The analyst says the pullback in the company's stock price is unwarranted, with its latest Q3 earnings beating expectations amid "continued healthy growth in fees and performance-related income". Biggar adds that the recent "market turbulence" will offer the company opportunities to deploy its "substantial cash holdings" in assets with future monetizations. The analyst further stated that its valuation premium to other alternative asset managers is "warranted by KKR's greater liquidity following its conversion to corporate status".
11/19/18
LEER
11/19/18
NO CHANGE
Target $42
LEER
Market Perform
Acadia selloff appears 'overdone,' says Leerink
Leerink analyst Ana Gupte views Acadia (ACHC) as being oversold after the CNBC newsflow on Friday around the issues ongoing with the sale process to KKR (KKR). The analyst notes that it is unclear to her if the strategic leak to CNBC is coming from the company itself to signal the end of the current sale process, or is a move from the current potential buyers in pursuit of a lower price. Gupte reiterates a Market Perform rating and $42 price target on Acadia shares.
01/04/19
GSCO
01/04/19
DOWNGRADE
Target $93
GSCO
Neutral
T. Rowe Price downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein downgraded T. Rowe Price (TROW) to Neutral with a $93 price target. The analyst also removed the shares of KKR (KKR) and IntercontinentalExchange (ICE) from his firm's Americas Conviction List, but keeps Buy ratings on both. Blostein continues to view T. Rowe as "one of the strongest active management franchises" in a challenging environment for traditional asset managers, but he believes "risks to the stock are building." Flows are likely to decelerate "meaningfully" as T. Rowe's three-year excess returns in parts on equities and particularly in fixed income are declining and broader retail rotation out of equities remains a risk, the analyst tells investors in a research note.
01/04/19
GSCO
01/04/19
DOWNGRADE
Target $27
GSCO
Buy
KKR downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein removed KKR from his firm's Americas Conviction List but keeps a Buy rating on the name. The analyst thinks the more challenging macro backdrop will likely be a headwind for the company's near-term cash earnings growth and book value growth. He still sees "significant upside" to his $27 12-month price target, but cautions that the "near-term path is less certain."
DIS Disney
$110.16

0.97 (0.89%)

02/06/19
LOOP
02/06/19
NO CHANGE
Target $130
LOOP
Buy
Disney generated strong fundamentals in Q1, says Loop Capital
Loop Capital analyst Alan Gould kept his Buy rating and $130 price target on Disney after its Q1 results, saying its strong fundamentals are leading into its continued pivot toward streaming business. The analyst points to the doubling of ESPN+ subscriptions to 2M over the past 5 months and expects the launch of Disney+ service to have a "much wider appeal". Gould also sees modest improvement in the traditional ESPN subscriber trend, another strong quarter for its Domestic Parks segment, and Hulu equity looses being "offset by program sales, advertising and affiliate fees."
02/06/19
MSCO
02/06/19
NO CHANGE
Target $135
MSCO
Overweight
Disney's ESPN+ has surprised with early sub growth, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said in a note before the open that Disney's (DIS) Q1 results were broadly ahead of expectations. He said that ESPN+ has surprised him with its early sub growth ahead of "all eyes" being on the launch of Disney+ this fall and the consolidation of Hulu after the Fox (FOXA) deal closes. Additionally, the $150M drag on operating income for FY19 was lower than expected given fears over lost licensing revenues as Disney opts to keep much of its film and TV content in house, said Swinburne. He continues to see Disney shares offering compelling value and keeps an Overweight rating on the stock with a $135 price target.
02/13/19
EDJN
02/13/19
UPGRADE
EDJN
Buy
Disney upgraded to Buy from Hold at Edward Jones
Edward Jones analyst Robin Diedrich upgraded Disney to Buy from Hold.
01/17/19
IMPC
01/17/19
NO CHANGE
Target $32
IMPC
Outperform
MSG Networks 7% pullback on Disney report unwarranted, says Imperial Capital
Shares of MSG Networks (MSGN) were down 7% on January 15 when the New York Post reported that Disney (DIS), which is required to sell off the Fox regional sports networks per a mandate from the Department of Justice, is having a "tough time" finding a buyer for the whole package, Imperial Capital analyst David Miller tells investors in a research note. The article seemed to imply that if the auction is not successful and Disney is forced to deploy a fire sale on the networks, and ends up receiving only five-to-six times EBITDA, that that is where MSG Networks should trade, says the analyst. He disagrees with this thought. The "mark" for MSG Networks is terminal value on YES only, not the other 21 regional sports networks, which are far less profitable, Miller contends. He maintains an Outperform rating on MSG Networks with a $32 price target.

TODAY'S FREE FLY STORIES

BMRN

BioMarin

$88.80

-1.82 (-2.01%)

07:26
02/22/19
02/22
07:26
02/22/19
07:26
Recommendations
BioMarin analyst commentary  »

BioMarin base business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$19.59

1 (5.38%)

07:26
02/22/19
02/22
07:26
02/22/19
07:26
Initiation
RA Pharmaceuticals initiated  »

RA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$38.98

-0.03 (-0.08%)

07:26
02/22/19
02/22
07:26
02/22/19
07:26
Periodicals
TSMC getting traction for AI, 5G 'boom' with its EUV process, DigiTimes says »

The upcoming Mobile World…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$41.10

-0.05 (-0.12%)

07:26
02/22/19
02/22
07:26
02/22/19
07:26
Downgrade
Teradyne rating change  »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 28

    May

INTU

Intuit

$234.85

-1.06 (-0.45%)

07:25
02/22/19
02/22
07:25
02/22/19
07:25
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

AAOI

Applied Optoelectronics

07:25
02/22/19
02/22
07:25
02/22/19
07:25
Downgrade
Applied Optoelectronics rating change  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

ANIK

Anika Therapeutics

$40.45

0.45 (1.13%)

07:24
02/22/19
02/22
07:24
02/22/19
07:24
Downgrade
Anika Therapeutics rating change  »

Anika Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$118.12

20.99 (21.61%)

07:24
02/22/19
02/22
07:24
02/22/19
07:24
Recommendations
Grand Canyon analyst commentary  »

Grand Canyon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIN

Dine Brands

$99.45

10.93 (12.35%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Recommendations
Dine Brands analyst commentary  »

Dine Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFRX

InflaRx

$31.65

-0.83 (-2.56%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Initiation
InflaRx initiated  »

InflaRx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNVGY

Lenovo

$0.00

(0.00%)

07:22
02/22/19
02/22
07:22
02/22/19
07:22
Upgrade
Lenovo rating change  »

Lenovo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GWPH

GW Pharmaceuticals

$143.86

-2.16 (-1.48%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Downgrade
Roku rating change  »

Roku downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$12.33

-0.32 (-2.53%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Hot Stocks
Navient issues statement regarding Canyon nomination of four directors for board »

Navient issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$32.22

-1.54 (-4.56%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Downgrade
Xencor rating change  »

Xencor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

07:19
02/22/19
02/22
07:19
02/22/19
07:19
Initiation
Global Blood Therapeutics initiated  »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$6.62

-0.03 (-0.45%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Downgrade
Fitbit rating change  »

Fitbit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

STMP

Stamps.com

, FDX

FedEx

$182.28

0.52 (0.29%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Recommendations
Stamps.com, FedEx, UPS, Amazon.com analyst commentary  »

Stamps.com should return…

STMP

Stamps.com

FDX

FedEx

$182.28

0.52 (0.29%)

UPS

UPS

$111.76

0.68 (0.61%)

AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ARGX

Argenx

$122.20

-2.84 (-2.27%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$418.66

-3.9 (-0.92%)

07:17
02/22/19
02/22
07:17
02/22/19
07:17
Initiation
Regeneron initiated  »

Regeneron assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

BIIB

Biogen

$320.99

-14.02 (-4.18%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Initiation
Biogen initiated  »

Biogen assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Hot Stocks
Starboard to nominate full slate for election to Magellan Health board »

Starboard Value, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MO

Altria Group

$50.38

-0.14 (-0.28%)

07:14
02/22/19
02/22
07:14
02/22/19
07:14
Periodicals
Despite flavored vape ban, Juul sees $3.4B in revenue in 2019, Bloomberg says »

Despite the fact that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$127.56

-2.17 (-1.67%)

07:12
02/22/19
02/22
07:12
02/22/19
07:12
Initiation
Alexion initiated  »

Alexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

MCRB

Seres Therapeutics

$5.83

-0.07 (-1.19%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.